Table of Contents Author Guidelines Submit a Manuscript
Bone Marrow Research
Volume 2012, Article ID 960280, 5 pages
http://dx.doi.org/10.1155/2012/960280
Review Article

Th17 Mediated Alloreactivity Is Facilitated by the Pre-Transplant Microbial Burden of the Recipient

1Department of Clinical Immunology, L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 Rudolfa Weigla Street, 53-114 Wroclaw, Poland
2Lower Silesian Center for Cellular Transplantation, National Bone Marrow Donor Registry, Grabiszyńska 105, 53-439 Wroclaw, Poland

Received 27 July 2012; Accepted 18 September 2012

Academic Editor: Bronwen Shaw

Copyright © 2012 Aleksandra Klimczak and Andrzej Lange. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. W. Choi, J. E. Levine, and J. L. M. Ferrara, “Pathogenesis and management of graft-versus-host disease,” Immunology and Allergy Clinics of North America, vol. 30, no. 1, pp. 75–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. J. Barrett, “Understanding and harnessing the graft-versus-leukaemia effect,” British Journal of Haematology, vol. 142, no. 6, pp. 877–888, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Lu, C. R. Giver, and A. Sharma, “IFN-gamma and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity,” Blood, vol. 119, pp. 1075–1085, 2012. View at Google Scholar
  4. V. K. Prasad and J. Kurtzberg, “Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions,” British Journal of Haematology, vol. 148, no. 3, pp. 356–372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Sackstein, “A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease,” Biology of Blood and Marrow Transplantation, vol. 12, no. 1, pp. 2–8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Ferrara, J. E. Levine, P. Reddy, and E. Holler, “Graft-versus-host disease,” The Lancet, vol. 373, no. 9674, pp. 1550–1561, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. W. Van Bekkum and S. Knaan, “Role of bacterial microflora in development of intestinal lesions from graft versus host reaction,” Journal of the National Cancer Institute, vol. 58, no. 3, pp. 787–790, 1977. View at Google Scholar · View at Scopus
  8. D. W. Van Bekkum, J. Roodenburg, P. J. Heidt, and D. Van Der Waaij, “Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora,” Journal of the National Cancer Institute, vol. 52, no. 2, pp. 401–404, 1974. View at Google Scholar · View at Scopus
  9. G. R. Hill and J. L. M. Ferrara, “The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation,” Blood, vol. 95, no. 9, pp. 2754–2759, 2000. View at Google Scholar · View at Scopus
  10. B. R. Blazar, W. J. Murphy, and M. Abedi, “Advances in graft-versus-host disease biology and therapy,” Nature Reviews Immunology, vol. 12, pp. 443–458, 2012. View at Google Scholar
  11. C. Calcaterra, L. Sfondrini, A. Rossini et al., “Critical role of TLR9 in acute graft-versus-host disease,” Journal of Immunology, vol. 181, no. 9, pp. 6132–6139, 2008. View at Google Scholar · View at Scopus
  12. O. Penack, E. Holler, and M. R. M. Van Den Brink, “Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors,” Blood, vol. 115, no. 10, pp. 1865–1872, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Heimesaat, A. Nogai, S. Bereswill et al., “MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease,” Gut, vol. 59, no. 8, pp. 1079–1087, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Imado, T. Iwasaki, S. Kitano et al., “The protective role of host Toll-like receptor-4 in acute graft-versus-host disease,” Transplantation, vol. 90, no. 10, pp. 1063–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Gerbitz, M. Schultz, A. Wilke et al., “Probiotic effects on experimental graft-versus-host disease: let them eat yogurt,” Blood, vol. 103, no. 11, pp. 4365–4367, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. R. R. Jenq, C. Ubeda, and Y. Taur, “Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation,” Journal of Experimental Medicine, vol. 209, pp. 903–911, 2012. View at Google Scholar
  17. D. W. Beelen, A. Elmaagacli, K. D. Müller, H. Hirche, and U. W. Schaefer, “Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft- versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial,” Blood, vol. 93, no. 10, pp. 3267–3275, 1999. View at Google Scholar · View at Scopus
  18. D. Berrebi, R. Maudinas, J. P. Hugot et al., “Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon,” Gut, vol. 52, no. 6, pp. 840–846, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Madrigal and B. E. Shaw, “Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation,” Blood Cells, Molecules, and Diseases, vol. 40, no. 1, pp. 40–43, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Holler, G. Rogler, H. Herfarth et al., “Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation,” Blood, vol. 104, no. 3, pp. 889–894, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Bogunia-Kubik, E. Jaskula, D. Dłubek, A. Wójtowicz, and A. Lange, “SNP8 of the NOD2/CARD15 gene and acute GvHD contribute to CMV reactivation after allogeneic haematopoietic stem cell transplantation,” Bone Marrow Transplantation, vol. 46, no. 1, supplement, p. S82, 2011. View at Google Scholar
  22. A. Lange, K. Suchnicki, S. Mizia, P. Czajka, A. Lach, and D. Dlubek, “Low blood levels of Th17 cells are seen in patients with aGvHD and associate with rather poor survival post HSCT,” Blood, vol. 118, abstract 4079, 2011. View at Google Scholar
  23. P. Reddy, “Pathophysiology of acute graft-versus-host disease,” Hematological Oncology, vol. 21, no. 4, pp. 149–161, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Klimczak and A. Lange, “Apoptosis of keratinocytes is associated with infiltration of CD8+ lymphocytes and accumulation of Ki67 antigen,” Bone Marrow Transplantation, vol. 26, no. 10, pp. 1077–1082, 2000. View at Google Scholar · View at Scopus
  25. T. A. Weaver and A. D. Kirk, “Alemtuzumab,” Transplantation, vol. 84, no. 12, pp. 1545–1547, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. G. R. Hill, J. M. Crawford, K. R. Cooke, Y. S. Brinson, L. Pan, and J. L. M. Ferrara, “Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines,” Blood, vol. 90, no. 8, pp. 3204–3213, 1997. View at Google Scholar · View at Scopus
  27. A. Lange, L. Karabon, A. Klimczak et al., “Serum interferon-γ and C-reactive protein levels as predictors of acute graft-vs-host disease in allogeneic hematopoietic precursor cell (marrow or peripheral blood progenitor cells) recipients,” Transplantation Proceedings, vol. 28, no. 6, pp. 3522–3525, 1996. View at Google Scholar · View at Scopus
  28. S. Murphy and V. H. Nguyen, “Role of gut microbiota in graft-versus-host disease,” Leukemia & Lymphoma, vol. 52, pp. 1844–1856, 2011. View at Google Scholar
  29. L. Karabon, A. Moniewska, A. Laba, C. Swider, and A. Lange, “IL-6 is present in sera of bone marrow-transplanted patients in aplastic period and high levels of IL-6 during acute graft-versus-host disease are associated with severe gut symptoms,” Annals of the New York Academy of Sciences, vol. 762, pp. 439–442, 1995. View at Google Scholar · View at Scopus
  30. S. Fuji, S. W. Kim, T. Fukuda et al., “Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation,” Biology of Blood and Marrow Transplantation, vol. 14, no. 5, pp. 510–517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. H. Niess, F. Leithäuser, G. Adler, and J. Reimann, “Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions,” Journal of Immunology, vol. 180, no. 1, pp. 559–568, 2008. View at Google Scholar · View at Scopus
  32. J. S. Serody and G. R. Hill, “The IL-17 differentiation pathway and its role in transplant outcome,” Biology of Blood and Marrow Transplantation, vol. 18, pp. S56–S61, 2012. View at Google Scholar
  33. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Chung and D. L. Kasper, “Microbiota-stimulated immune mechanisms to maintain gut homeostasis,” Current Opinion in Immunology, vol. 22, no. 4, pp. 455–460, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Klimczak, A. Lach, E. Jaskula, and A. Lange, “IL-17 and CCR6 positive cells are present in the skin and gut with toxic lesions and even more pronounced in aGvHD,” Bone Marrow Transplantation, vol. 46, supplement 1, p. S102, 2011. View at Google Scholar
  36. R. Varona, V. Cadenas, L. Gómez, C. Martínez-A, and G. Márquez, “CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses,” Blood, vol. 106, no. 1, pp. 18–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Wang, S. G. Kang, J. Lee, Z. Sun, and C. H. Kim, “The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut,” Mucosal Immunology, vol. 2, no. 2, pp. 173–183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Dander, A. Balduzzi, G. Zappa et al., “Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation,” Transplantation, vol. 88, no. 11, pp. 1261–1272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Dlubek, E. Turlej, M. Sedzimirska, J. Lange, and A. Lange, “Interleukin-17-producing cells increase among CD4+ lymphocytes before overt manifestation of acute graft-versus-host disease,” Transplantation Proceedings, vol. 42, no. 8, pp. 3277–3279, 2010. View at Publisher · View at Google Scholar · View at Scopus